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The primary malignant melanoma of the uterine cervix is rare, usually diagnosed at an advanced stage and with poor prognosis.
The diagnosis is made through histological evaluation and confirmed by special staining procedures. Radical surgery has been
used and advocated. However in its advanced stages chemotherapy, immunotherapy or radiotherapy can be employed. A case of a
patient with malignant melanoma of the uterine cervix, Stage IIIb, is presented in addition to a clinical and pathological discussion.
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INTRODUCTION
Despite the increase in incidence of skin melanomain recent decades, it is rare in the lower genitaltract, being approximately 3% to 7% of all cases.
The majority these tumors arise on the vulva and then on
the vagina1,2 Primary melanoma of the cervix is rare, with
about 35 cases described in the literature.3 No
predominance of any age group has been observed and
these patients have ranged in age from 26 to 74 years.2,3
The clinical history usually includes abnormal genital
bleeding, and physical examination reveals an exophytic
cervical mass, pigmented or otherwise, usually involving
the vaginal fornices in more than 50% of the cases at the
time of diagnosis.2,4 The malignant cells with their melanic
pigment can be detected via the cervical smear. Diagnosis
is confirmed by the histological examination and
immunohistochemical staining.1,3 Management of such
cases has included radical surgery, irradiation and immuno
or chemotherapy, although even with good therapeutic
results, the survival time is short.1,2
A case of primary malignant melanoma of the cervix,
Stage IIIb, is presented with its diagnosis and treatment.
CASE REPORT
A 65-year-old white woman with a 2-month history
of vaginal bleeding and pelvic pain, began treatment in
our care in July 1994. On physical examination an
exophytic cervical mass was observed, 6 cm in diameter,
ulcerated with darkened borders, involving the vaginal
fornices and parametrial invasion up to the pelvic wall.
The pelvic ultrasonography showed a uterine cervix of
6.4 x 4.5 cm, having heterogeneous texture. Computed
tomography of the abdomen and pelvis demonstrated a
large-sized pelvic tumor. The proctosigmoidoscopy,
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cystoscopy, chest radiograph, fundoscopic exam and
computed tomography of the cranium were normal.
Biopsy of the lesion was performed and the
pathological diagnosis was undifferentiated neoplasm
composed of spindle-shaped cells containing mitotically
active dark pleomorphic nuclei containing prominent
nucleoli (Figs. 1 and 2). The mitotic count was more than
10 mitoses per 10 high power fields. Cytoplasmic pigment
was not observed and immunohistochemical staining was
done to distinguish it from other neoplasms, like spindle
cell carcinoma and sarcoma. Immunohistochemical stains
showed strong reactivity for the S-100 protein and for the
melanoma-specific antibody HMB-45, and absence of
immunoreactivity for epithelial antigens. A vaginal biopsy
showed pigmented malignant neoplasia, with in situ
melanoma and focuses of superficial invasion, whose
histological diagnosis was pigmented malignant melanoma
of the lentiginous type (Fig. 3).
With a diagnosis of locally advanced primary
malignant melanoma of the uterine cervix, and also
because the patient presented Hansen’s disease in the
reactional phase and reduced kidney function, external
pelvic irradiation with megavoltage was started. After the
application of 3420 cGy, an absence of response was
observed and the patient then abandoned the treatment.
Through phone contact we were informed of the death of
the patient 6 months after the diagnosis.
DISCUSSION
Melanoma of the cervix is a rare and aggressive
neoplasia. About 60% of the cases already had clinical
evidence of tumor beyond the cervix at the time of
diagnosis2,3 and the 5-year survival rate decreases from
40% for Stage I to 14% for other stages.4 Due to the rarity
of the primary melanoma of the cervix, the possibility of
metastatic neoplasia coming from a melanoma at a different
site, or which may have been treated several years before,
must always be investigated. In some cases it is impossible
to locate the primary site of the disease. The case described
did not have a history of any other melanoma, the largest
tumoral volume being in the uterine cervix and spreading
to the vagina. Moreover, the lentiginous pigmented
malignant neoplasia of the vagina, with its in situ
melanoma and focus of superficial invasion, is conclusive
as to its primary origin in the lower genital tract. According
to the literature, malignant melanoma of the cervix has a
poor prognosis and is frequently associated with vaginal
Figure 1 - The cervical biopsy showed a solid proliferation of
undifferentiated malignant neoplasm with spindle-shaped cells.
Hematoxylin and eosin, x50.
Figure 2 - At higher power, the cervical biopsy demonstrates
malignant cells with pleomorphic nuclei, and prominent nucleoli
and frequent mitosis. Hematoxylin and eosin, x100.
Figure 3 - Vaginal biopsy showed cells pigmented by melanoma,
superficially invasive into the stroma. Hematoxylin and eosin, x50.
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disease, whether from direct extension of the cervix or
due to metastasis.3,4
There is no defined treatment. According to the
spreading pattern of the tumor, the patient could be treated
with radical hysterectomy, pelvic lymphadenectomy and
total colpectomy. Despite the low radiation sensitivity of
melanomas, radiotherapy can be indicated when surgery
is not complete or not possible. However, the results are
limited, even when associated with immunotherapy or
chemotherapy.1,2 Survival is usually short due to metastasis,
independently of the local disease control.1,2,4
Thus, only by early detection via preventive
gynecological examination and periodic cervical smears
can the disease be detected in its early stages, which may
contribute to an increase in survival time. In the present
case the patient had the disease in an advanced stage and
the proposed radiotherapy was only palliative and
incomplete, resulting in short survival.
RESUMO
O melanoma primário do colo uterino é raro, geralmente diagnosticado em estádio avançado e com pobre prognóstico. O
diagnóstico é feito através da avaliação histológica e confirmado por colorações especiais. A cirurgia radical tem sido preconizada.
Contudo, nos estádios avançados, a quimioterapia, imunoterapia ou radioterapia podem ser empregadas. O caso de uma
paciente com melanoma malígno do colo uterino estádio IIIb é apresentado juntamente com sua discussão clínica e patológica.
REFERENCES
1. Kristiansen SB, Anderson R, Cohen DM. Primary malignant
melanoma of the cervix and review of the literature. Gynecol
Oncol 1992;47:398-403.
2. Morrow CP, DiSaia PJ. Malignant melanoma of the female
genitalia: a clinical analysis. Obstet Gynecol Surv
1976;31:233-71.
3. Clement PB, Young RH. Tumors and tumorlike lesions of
the uterine corpus and cervix. New York: Churchill
Livingstone 1993:393-5.
4. Mordel C, Mor-Yoset S, Ben-Baruch N, Anteby SO.
Malignant melanoma of the uterine cervix: case report and
review of the literature. Gynecol Oncol 1989;32:375-80.
Teixeira JC, Salina JR, Teixeira LC, Andrade LALA. Primary melanoma of the uterine
cervix figo stage III B.
Rev Paul Med 1998;116(4):1778-80
